Hybrid Tumor Vaccines. David L. Liu, MD, PhD Professor of Surgery and Oncology Tumor Immunotherapy Division RedSun Institut e 242 Dorchester Street, Boston, MA02127 , USA.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
David L. Liu, MD, PhD
Professor of Surgery and Oncology
Tumor Immunotherapy Division
242 Dorchester Street, Boston, MA02127, USA
Tumor is a gene-mutated or molecule-mutated disease. Therefore, tumor cells should have expressed one or multiple types of tumor-specific antigens. Unfortunately, the immune system of the body does not recognize tumor-specific antigens because their weak immunogenicity, which leads to escape of tumor cells from immune surveillance.